Paper Details
- Home
- Paper Details
Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase.
Author: BensonC, DarpoB, DotaC, FerberG, GarnettC, GreenC L, JarugulaV, JohannesenL, KeirnsJ, KrudysK, LiuJ, Ortemann-RenonC, RileyS, SarapaN, SmithB, StockbridgeN, StoltzR R, ZhouM
Original Abstract of the Article :
The QT effects of five "QT-positive" and one negative drug were tested to evaluate whether exposure-response analysis can detect QT effects in a small study with healthy subjects. Each drug was given to nine subjects (six for placebo) in two dose levels; positive drugs were chosen to cause 10 to 12 ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1002/cpt.60
データ提供:米国国立医学図書館(NLM)
QT Assessment in Early Clinical Trials: A Paradigm Shift
This study investigated the feasibility of replacing the traditional thorough QT study with a more efficient and robust QT assessment in the early clinical phase of drug development. The researchers evaluated the QT effects of six drugs, including five known to prolong QT intervals and one negative control drug, using a small cohort of healthy subjects.Exposure-Response Analysis: A Promising Alternative to Thorough QT Studies
The study demonstrated that exposure-response analysis could effectively detect QT effects in a small study with healthy subjects. The findings suggest that this approach can potentially replace the more resource-intensive thorough QT study, streamlining the drug development process while maintaining safety and efficacy.Efficient and Robust QT Assessment: A Valuable Tool for Drug Development
This study highlights the potential of robust QT assessment in early-phase clinical studies as a valuable tool for drug development. The approach offers a more efficient and cost-effective method for detecting QT effects, potentially leading to faster and more efficient drug development.Dr. Camel's Conclusion
This study explores a potential paradigm shift in drug development by advocating for a more efficient and robust QT assessment in early clinical phases. The researchers demonstrate the effectiveness of exposure-response analysis in detecting QT effects in a small study, potentially revolutionizing the traditional approach to QT evaluation.Date :
- Date Completed 2015-05-12
- Date Revised 2015-06-16
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.